Related Experiment Video
Updated: Jun 10, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis
Till Bärnighausen1, Thomas A McWalter, Zachary Rosner
1Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA.
Tests for recent HIV infection, like the BED assay, are crucial for tracking the epidemic. However, many studies do not adequately account for assay imperfections, potentially affecting HIV incidence estimates.
Area of Science:
- Epidemiology
- Public Health
- Biostatistics
Background:
- HIV incidence estimation is vital for understanding epidemic trends and intervention effectiveness.
- Tests for recent HIV infection enable incidence estimation from cross-sectional surveys.
- The BED IgG-Capture Enzyme Immunoassay (BED assay) is a widely utilized commercial test for recent HIV infection.
Purpose of the Study:
- To systematically review studies using the BED assay for HIV incidence estimation.
- To investigate the sensitivity of incidence estimates to various methodological and parameter choices.
- To identify limitations and provide recommendations for improving future BED assay studies.
Main Methods:
- A systematic literature search identified 1181 unique studies, with 39 included in the final review.
- Reviews assessed study methodologies, including incidence formulae and parameter choices.
- Sensitivity analyses were performed to evaluate the impact of different estimation methods and parameters.
Main Results:
- BED assay surveys have been conducted globally across diverse populations.
- Most studies failed to account for assay imperfection or use locally valid calibration parameters.
- Incidence estimates demonstrated high sensitivity to methodological and parameter choices.
- Confidence intervals often omitted parameter uncertainty.
Conclusions:
- BED assay surveys can yield valid HIV incidence estimates when properly conducted.
- Insufficient accounting for assay imperfection is a common limitation in current studies.
- Future research should prioritize reporting complete data, using unbiased estimators with local parameters, and incorporating parameter uncertainty in confidence intervals.
More Related Videos
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
11:19Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
Published on: May 4, 2015